Patent ID: 11965028
Assignee: THERANOVIR
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 1:
2. The antibody or antibody fragment of claim 1 comprising the following CDRs:
CDR-H1: SFGMH (SEQ ID NO: 7),
CDR-H2: YISSGSSTIHYADTVKG (SEQ ID NO: 8),
CDR-H3: RHYGSSRYWYFDV (SEQ ID NO: 9),
CDR-L1: KASQDIKSYLS (SEQ ID NO: 10),
CDR-L2: YATSLAG (SEQ ID NO: 11), and
CDR-L3: LQYGESPYT (SEQ ID NO: 12).